Our Mission

To improve the Quality of Life of patients around the world through the design, development and delivery of the highest quality innovative therapeutic solutions.

Our Company Shared Values – TEAMWORK

  • teamwork-t


    in each other

  • teamwork-e


    in everything we do

  • teamwork-a


    for actions and results

  • teamwork-m

    Market Driven

    decision making

  • teamwork-w


    to learn and grow

  • teamwork-o

    Open Minded

    to new ideas and change

  • teamwork-r


    for self and others

  • teamwork-k


    of our business and goals

Our Story

You may have heard of Repro Med Systems, Inc. That’s us! Today, we are operating as RMS Medical Products, a leading developer and manufacturer of medical devices and supplies. The company was incorporated in March, 1980 and is now publicly traded . Our stock symbol is REPR.

Worldwide, RMS Medical Products drives healthcare inspiration – in the minds of our patients, our employees, our customers and our shareholders – to give everyone greater freedom for living. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.

We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers, and careful consideration for the patient experience. Our primary products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™ and RES-Q-VAC® Hand Held Medical Suction.

We are passionate about helping people with our reliable medical devices made at our HQ in Chester, NY (USA). Our products, as well as product support, are offered worldwide by RMS and through a global network of distributors and service providers.

RMS is excited to expand into new markets with innovative, more technical products. We look forward to productive partnerships with people and companies who share our vision and can help us effectively deliver our value promise to stakeholders in our industry.

Our Latest News & Updates

RMS April 23, 2018 Annual Shareholder Meeting Presentation

2017 Breakthrough Year Highlights Highest Reported Twelve Month Net Sales and Net Income in RMS History 25% Increase in Net Sales 21% Increase in Gross Profit 12% Decrease in Operating Expenses as % of Net Sales 7% Increase in Net Income as % of Net Sales

Meet Our Executive Team

  • Andrew Sealfon

    CEO, President, Chairman of the Board of Directors, Co-Founder

    Andrew Sealfon, President of the company and Chairman of the Board of Directors, co-founded the Company in 1980.  He has held various positions including Chief Financial Officer and Director of Sales. He has been responsible for corporate management and for directing the design, development and sales of the Company’s products. His current work is in the design of infusion peripherals including syringe pumps and subcutaneous administration sets for use with immune globulins. His research has culminated with the widespread use of the Freedom60 Syringe Infusion System for SCIG, and High-Flo RMS Subcutaneous Needle Sets. This research continues to demonstrate that an optimum infusion—both subcutaneous and intravenous—can be greatly influenced by the ancillary equipment.

    Mr. Sealfon is an electrical engineer and inventor and has been granted numerous U.S. patents. As an aerospace engineer, Mr. Sealfon was employed by ITT Federal Laboratories Defense Space Group as a Member of the Technical Staff, and later was a Member of the Research Staff of Riverside Research Institute. Mr. Sealfon is a graduate of Lafayette College and continued his graduate studies at Polytechnic Institute of Brooklyn.

  • Dr. Fred Ma


    Dr. Fred Ma brings over 30 years of broad experience based on his neurosurgical practice, with significant emphasis in pharmaceuticals and medical device industries. Dr. Ma has a successful track record in all phases of product research and development culminating in final approvals, clearances, and commercialization. He is prominent within regulatory agencies and a multitude of professional organizations. Dr. Ma has directly designed and supervised numerous product developments, 600 clinical trials and many successful regulatory approvals and clearances worldwide.  He ushers in significant business growth with noteworthy achievement in bringing new products to market with agile skill. Dr. Ma earned his M.D. degree from Capital University of Medical Sciences, Beijing, D.M.Sc. (Doctorate of Medical Sciences (equivalent to combined M.D. and Ph.D. degrees) from Tokyo University, Japan, and a Ph.D. from Rutgers University.

  • Karen Fisher


    Karen Fisher has more than 25 years of financial experience in a variety of industries, most recently serving as the Assistant Controller for a global consumer products company. She has also held roles such as Chief Accounting Officer and Treasurer, and Controller. Ms. Fisher held multiple financial management roles covering financial analysis and reporting, budgeting, forecasting, acquisitions, and cash management.  She is thoroughly knowledgeable in compliance with SEC regulation, GAAP, 10Q’s, 10K’s and Sarbanes-Oxley.  Ms. Fisher is a Certified Public Accountant and a graduate of Arizona State University with a BS in Accounting.

  • Manuel Marques

    VP Operations

    Manny Marques has an engineering background in FDA Class II & III medical devices. He has a proven history of effectively transferring new products from R&D into manufacturing, while also reducing operating and manufacturing costs of existing products. Mr. Marques is a champion at enhancing operational management via implementation of Lean 6-Sigma Manufacturing techniques.  Mr. Marques holds two U.S. patents for cardiovascular medical devices.  Manny obtained a BS in Mechanical Engineering Technology and also an MS in Engineering Management from the New Jersey Institute of Technology.

Investor Relations